Search Results - "Esmy, Pulikottil O."
-
1
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study
Published in PloS one (29-12-2020)“…In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as…”
Get full text
Journal Article -
2
Socio Demographic and Reproductive Risk Factors for Cervical Cancer - a Large Prospective Cohort Study from Rural India
Published in Asian Pacific journal of cancer prevention : APJCP (2012)“…Background: India shows some of the highest rates of cervical cancer worldwide, and more than 70% of the population is living in rural villages. Prospective…”
Get full text
Journal Article -
3
Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural south India
Published in International journal of gynecology and obstetrics (01-05-2015)“…Abstract Objective To estimate the long-term risk of cervical cancer among women screened by visual inspection with acetic acid (VIA) and to evaluate the…”
Get full text
Journal Article -
4
Socio demographic and reproductive risk factors for cervical cancer - a large prospective cohort study from rural India
Published in Asian Pacific journal of cancer prevention : APJCP (01-01-2012)“…India shows some of the highest rates of cervical cancer worldwide, and more than 70% of the population is living in rural villages. Prospective cohort studies…”
Get full text
Journal Article -
5
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study
Published in Papillomavirus research (01-06-2019)“…Earlier publication from the ongoing multi-centric study of the International Agency for Research on Cancer to evaluate less than three doses of the…”
Get full text
Journal Article -
6
Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India
Published in Papillomavirus research (01-06-2018)“…Extending two-dose recommendations of HPV vaccine to girls between 15 and 18 years will reduce program cost and improve compliance. Immunogenicity and vaccine…”
Get full text
Journal Article